Effects of Moringa oleifera on inflammation, oxidative stress, and bone-related changes in a rat model of experimental periodontitis Authors: Mert Keles, Fatma Ucan Yarkac, Rahim Kocabas, Fahriye Kilinc Published: 2026 ABSTRACT AbstractBackgroundThis study evaluated the effects of Moringa oleifera (MO) on inflammatory, oxidative stress, and bone-related changes in a rat model of ligature-induced experimental periodontitis.MethodsForty male Wistar rats were randomly assigned to five groups: healthy control (C), periodontitis (P), and periodontitis treated with MO at 100, 200, or 400 mg/kg/day (P + MO100, P + MO200, P + MO400). Periodontitis was induced by placing silk ligatures around the mandibular first molars for 14 days, followed by 4 weeks of daily oral MO administration. Serum levels of IL-1β, IL-6, TNF-α, malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) were measured by ELISA. Histopathological evaluation included inflammatory cell, osteoblast, and osteoclast counts, and histomorphometric analysis assessed alveolar bone level (ABL). Group comparisons were performed using the Kruskal–Wallis test with Dunn's post-hoc test and Holm adjustment.ResultsSignificant overall group differences were observed for inflammatory cytokines, oxidative stress, antioxidant parameters, histopathological findings, and ABL. Compared with the P group, the P + MO200 and P + MO400 groups showed a more favorable profile, particularly for IL-6, IL-1β, SOD, GPx, and MDA after multiple-comparison adjustment. Histopathological findings also supported a more favorable pattern in these higher-dose groups. Although ABL differed significantly overall, pairwise differences were limited after adjustment. Serum urea, creatinine, ALT, and AST levels did not differ significantly among groups.ConclusionMO was associated with favorable anti-inflammatory, antioxidant, and bone-related changes in experimental periodontitis, with clearer effects at 200 and 400 mg/kg/day. Further studies are needed to confirm its translational potential.Keywords: Alveolar bone loss, Antioxidants, Experimental periodontitis, Moringa oleifera, Oxidative stress Introduction Periodontitis is a biofilm-associated inflammatory disease and a major cause of tooth loss.1 Bacterial products stimulate the release of proinflammatory mediators such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, which contribute to connective tissue breakdown and alveolar bone destruction.2 In addition to inflammatory signaling, reactive oxygen species (ROS) generated mainly by activated neutrophils play an important role in periodontal tissue injury by promoting oxidative stress and disturbing bone homeostasis.3, 4, 5. Antioxidants can prevent cellular damage caused by free radicals.6 Superoxide dismutase (SOD), glutathione peroxidase (GPx), α-tocopherol (vitamin E), ascorbate (vitamin C), and polyphenols (flavonoids) are important antioxidants.7 While there is a balance between ROS and antioxidant products in healthy individuals, it is accepted that the oxidant/antioxidant system balance is disrupted in periodontal diseases due to excessive ROS production and/or a defect in antioxidant activity.8 Moringa oleifera (MO) is a plant known as the "Tree of Life" or "Miracle Tree" that is generally cultivated in countries such as Thailand, India, the Philippines, and Pakistan.9 MO is rich in bioactive compounds, including flavonoids and vitamins, and has been reported to exert anti-inflammatory effects by reducing TNF-α, IL-6, IL-1β, and nuclear factor kappa B (NF-κB) levels in experimental models.10, 11, 12, 13, 14, 15 These properties suggest that MO may have therapeutic potential in conditions characterized by chronic inflammation and oxidative stress, including periodontitis. Although MO has been associated with beneficial systemic effects in several experimental models, only limited evidence is available regarding its role in periodontal disease. Therefore, the aim of this study was to evaluate the effects of MO administration at three oral dose levels on inflammatory cytokines, oxidative stress parameters, histopathological findings, and histomorphometric alveolar bone loss in a rat model of experimental periodontitis. The null hypothesis was that MO administration would produce no significant change in these parameters compared with untreated periodontitis. Materials and methods Experimental animal procurement and modeling The study protocol was approved by the Institutional Animal Research Ethics Committee (Approval No: blinded for peer review). The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were taken into consideration in the study design, conduct, and preparation of the manuscript. The sample size was determined with reference to a similar study and provided a statistical power of 80%.16 A total of 40 male Wistar albino rats aged 4–5 months and weighing 250–300 g were used in this study. Each animal was housed in a separate cage under standardized environmental conditions, including a controlled day/night cycle, 15 air changes per hour, a relative humidity of approximately 50 ± 3%, and a constant ambient temperature of 22 ± 1°C. Animals were distributed using simple randomization into five experimental groups: Control group (C, n = 8), Periodontitis group (P, n = 8), Periodontitis +100 mg/kg MO group (P + MO100, n = 8), Periodontitis +200 mg/kg MO group (P + MO200, n = 8), Periodontitis +400 mg/kg MO group (P + MO400, n = 8). A computer-generated random number list was generated using the RAND function in Microsoft Excel. Each animal was assigned to a group based on its position in the sorted random number list. Inclusion and exclusion criteria In this study, healthy male Wistar albino rats aged 4–5 months and weighing 250–300 g were included based on predefined inclusion criteria. During the experimental procedure, no animals exhibited unexpected health issues or complications requiring exclusion. However, in the histomorphometric analysis, some samples were excluded due to technical reasons such as tissue loss or debris in microsections, which rendered them unsuitable for evaluation. These exclusion criteria were not established a priori but were applied during the analysis phase due to technical necessity. For each analysis, the exact number of animals (n) included in each group is clearly stated in the corresponding tables. Apart from the histomorphometric exclusions, no data points or animals were omitted, and all rats were included in the remaining analyses. Induction of experimental periodontitis Experimental periodontitis was induced under general anesthesia by placing 4-0 silk ligatures (details blinded for peer review) around the mandibular first molars on both the right and left sides. The ligatures were carefully positioned subgingivally and tightly secured by an experienced clinician. Intraperitoneal anesthesia was achieved with ketamine-xylazine (75-10 mg/kg) (details blinded for peer review). All ligatures were checked after placement to ensure proper positioning, and any dislodged or loosened sutures were immediately replaced. On day 15, ligatures were removed from anesthetized subjects. All animals were monitored for a period of six weeks. Preparation of Moringa oleifera extract Dried MO leaf material originating from India and supplied by an academic institution (details blinded for peer review) was used for extract preparation. Initially, 50 g of dried leaf material was ground until it was fine enough to pass through a 1.6 mm sieve. The resulting powder was mixed with 250 mL methanol and centrifuged at 4500 rpm for 5 min to obtain a methanolic extract. The solid residue was discarded, and the supernatant was transferred to a beaker. To isolate the extract in powdered form, the methanol in the supernatant was first partially evaporated by heating at 70°C for 4 h. The remaining solvent was removed by placing the sample in an oven at 40°C for 48 h, allowing complete drying. The dried extract was then scraped from the container and milled for 5 min to ensure uniform particle size. The extraction yield from the dried powder was 11.5 ± 1.5%. Application of Moringa oleifera MO was administered once daily at doses of 100, 200, or 400 mg/kg body weight, in accordance with previous animal studies.17,18 For administration, the dried extract was dissolved in distilled water and freshly prepared each day before oral gavage. Each daily dose was adjusted according to body weight and delivered at 13:00 using a 1 mL syringe. After 4 weeks of treatment, animals were anesthetized with ketamine–xylazine (50 mg/kg and 10 mg/kg, respectively) (Manufacturer, Country), and blood samples and bone tissues were collected. In total, the experimental protocol lasted 6 weeks, consisting of 2 weeks of ligature-induced periodontitis induction followed by 4 weeks of MO administration, after which all animals were sacrificed for analysis. Collection of serum and mandibular specimens Cardiac blood was collected from all animals during the daytime (at 13:00) and transferred into tubes for serum separation. The blood samples were centrifuged at 2000 g for 10 min, and the obtained serum was used for biochemical analysis. For histological and histomorphometric evaluation, mandibular specimens were harvested and fixed in 10% neutral-buffered formaldehyde.19 Evaluation of the levels of serum inflammatory markers, oxidative stress, and antioxidant parameters Serum levels of inflammatory cytokines (IL-1β, IL-6, TNF-α) as well as oxidative stress and antioxidant markers (SOD, MDA, GPx) were measured using rat-specific enzyme-linked immunosorbent assay (ELISA) kits (Manufacturer, Country). The concentration of each biomarker is reported as mean values (pg/ml) ± standard deviation (SD). These serum-based biomarkers were selected to evaluate the systemic inflammatory and oxidative response associated with ligature-induced periodontitis and MO administration. To complement these systemic findings with site-related evidence, histopathological cell counts and histomorphometric alveolar bone level measurements were also performed on mandibular tissues. In order to evaluate the systemic safety of MO administration, liver (ALT, AST) and kidney (urea, creatinine) function parameters were analyzed at the end of the experimental period. All spectrophotometric measurements and biochemical analyses were performed by a blinded researcher who had no knowledge of group assignment following standardized protocols. Histopathological evaluation All animals were euthanized after four weeks and hard tissue samples (mandibular alveolar bone segments obtained from ligature-induced first molars) were collected and transported to the laboratory in 10% formalin solution. For histopathological analysis, tissues were first fixed in formalin for 48 h and decalcified in 10% formic acid. The decalcifying solution was refreshed weekly, and the process was completed within 4 to 6 weeks. Tissue sections with a thickness of 4–5 μm were obtained from paraffin-embedded blocks using a microtome and placed on a slide. They were then stained with hematoxylin and eosin (H&E). Microscopic evaluation focused on periodontal soft tissues, alveolar bone structures, osteoblasts, osteoclasts, and inflammatory cell infiltration. To ensure objectivity, group assignments were made by a blinded, trained researcher. Cellular analysis was performed under a light microscope equipped with a digital camera system (Fig. 1). Osteoblasts were identified as cuboidal cells aligned along the surface of the alveolar bone, while osteoclasts were recognized as multinucleated cells with irregular, curved borders. Inflammatory cells were also counted and documented within the periodontal tissues.20,21 Neutrophils, lymphocytes, eosinophils, and plasmocytes were counted as inflammatory cells. Cell counting was performed in 10 high-power fields (HPFs). Representative histopathological images showing osteoblast and osteoclast cells in the study groups. (a) Group C, (b) Group P, (c) Group P + MO100, (d) Group P + MO200, and (e) Group P + MO400. The triangle indicates the alveolar bone crest (ABC), the star indicates the cementoenamel junction (CEJ), the black arrow indicates osteoblasts, and the white arrow indicates osteoclasts. Scale bar = 200 μm. Histomorphometric evaluation For histomorphometric evaluation, the alveolar bone level (ABL) was determined by measuring the distance between the cementoenamel junction (CEJ) and the alveolar bone crest (ABC) (Fig. 2). The alveolar bone level (ABL) was measured at three different points on the buccal surface of the first molar teeth ligated with ligatures: the mesial, distal, and furcation regions. The average value of these three measurements was used as the ABL value for each sample and expressed in micrometers (μm). Thus, the unit of analysis for histomorphometry was the sample/animal rather than the individual measurement site.22 Representative images of histomorphometric alveolar bone level measurements. For the first molar, the distance between the cementoenamel junction (CEJ) and the alveolar bone crest (ABC) was measured at three buccal sites: (a) mesial, (b) furcation, and (c) distal. Scale bar = 200 μm. The alveolar bone levels in the groups are shown in Fig. 3. The triangular shape represents ABC, and the star shape represents CEJ. The images obtained using a digital camera were evaluated using an image analysis system (Olympus cellSens Standard 1.18) by a blinded pathologist who was unaware of the group allocation. To assess intra-observer reliability, repeated measurements were performed in 10 animals (corresponding to at least 20% of the sample) at a 2-week interval, and the intraclass correlation coefficient (ICC) was 0.88. Representative histomorphometric images of alveolar bone level in the study groups. (a) Group C, (b) Group P, (c) Group P + MO100, (d) Group P + MO200, and (e) Group P + MO400. The triangle indicates the alveolar bone crest (ABC), and the star indicates the cementoenamel junction (CEJ). Scale bar = 200 μm. Statistical analysis of the data Shapiro-Wilk test was used to evaluate the normality of the data distribution. Since the results of the normality tests indicated that the data did not follow a normal distribution, nonparametric methods were applied. Comparisons among the five groups were performed using the Kruskal-Wallis test. When the overall group comparison was statistically significant and pairwise interpretation was considered relevant, pairwise comparisons were conducted using Dunn's post-hoc test with Holm adjustment for multiple testing. Exact p-values are reported where applicable. In addition, effect sizes for overall group comparisons were calculated using epsilon-squared (ε2). A p-value less than 0.05 was considered statistically significant after adjustment. Sample size estimation was performed using GPower software (Heinrich-Heine-University, Düsseldorf, Germany). A Kruskal-Wallis test was selected for five independent groups. Based on an estimated large effect size (W = 0.55), a significance level (α) of 0.05, and a statistical power (1–β) of 0.80, the required sample size per group was calculated as 8 animals, totaling 40 animals. Results This study was completed with forty rats. In 32 of the rats, a ligature was attached to the cervical first molars of the mandible to induce experimental periodontitis. The ligatures remained in place for 15 days, after which they were removed. MO was administered for 4 weeks, and all animals were sacrificed at the end of the experiment. Serum inflammatory, oxidative stress, and antioxidant parameters Serum inflammatory cytokines (IL-6, TNF-α, and IL-1β), oxidative stress marker (MDA), and antioxidant enzymes (SOD and GPx) showed significant overall differences among the groups. According to the Kruskal-Wallis test, significant group effects were observed for IL-6 (H = 24.304, p < 0.001, ε2 = 0.580), TNF-α (H = 23.010, p < 0.001, ε2 = 0.543), IL-1β (H = 28.447, p < 0.001, ε2 = 0.698), SOD (H = 22.878, p < 0.001, ε2 = 0.539), MDA (H = 20.295, p < 0.001, ε2 = 0.466), and GPx (H = 36.647, p < 0.001, ε2 = 0.933) (Table 1, Table 2). Table 1Concentrations of inflammatory cytokines (IL-6, TNF-α and IL-1β), oxidative stress and antioxidant enzymes (SOD, MDA and GPx) in the experimental groups.Table 1Group CGroup PGroup P + MO100Group P + MO200Group P + MO400IL-6 (pg/ml)4.17 ± 3.4714.28 ± 5.129.37 ± 2.724.42 ± 1.514.66 ± 2.52TNF-α (pg/ml)50.63 ± 17.80370.42 ± 113.96324.89 ± 84.52261.63 ± 21.13266.82 ± 40.25IL-1β (pg/ml)4.23 ± 2.5221.97 ± 12.3317.56 ± 10.675.24 ± 1.455.27 ± 1.45SOD (ng/ml)5.16 ± 0.074.67 ± 0.184.91 ± 0.575.21 ± 0.315.38 ± 0.05MDA (ng/ml)6.29 ± 0.226.67 ± 0.126.54 ± 0.156.34 ± 0.166.38 ± 0.20GPx (pg/ml)5.80 ± 0.035.18 ± 0.035.84 ± 0.036.53 ± 0.016.64 ± 0.03C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin-1 beta; SOD, superoxide dismutase; MDA, malondialdehyde; GPx, glutathione peroxidase. Data are presented as mean ± standard deviation. Concentrations of inflammatory cytokines (IL-6, TNF-α and IL-1β), oxidative stress and antioxidant enzymes (SOD, MDA and GPx) in the experimental groups. C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin-1 beta; SOD, superoxide dismutase; MDA, malondialdehyde; GPx, glutathione peroxidase. Data are presented as mean ± standard deviation. Table 2Kruskal-Wallis test results, effect sizes, and significant pairwise comparisons for serum inflammatory, oxidative stress, and antioxidant parameters.Table 2VariableHp-valueε2Significant pairwise comparisons (Dunn-Holm adjusted p)IL-6 (pg/ml)24.304<0.0010.580P vs C, p < 0.001; P vs P + MO200, p = 0.002; P vs P + MO400, p = 0.002TNF-α (pg/ml)23.010<0.0010.543C vs P, p < 0.001; C vs P + MO100, p = 0.001; C vs P + MO200, p = 0.034IL-1β (pg/ml)28.447<0.0010.698P vs C, p < 0.001; P vs P + MO200, p = 0.005; P vs P + MO400, p = 0.006; P + MO100 vs P + MO200, p = 0.018SOD (ng/ml)22.878<0.0010.539P vs P + MO200, p = 0.024; P vs P + MO400, p < 0.001; C vs P + MO400, p = 0.050; P + MO100 vs P + MO400, p = 0.050MDA (ng/ml)20.295<0.0010.466P vs C, p = 0.005; P vs P + MO200, p = 0.002; P vs P + MO400, p = 0.022GPx (pg/ml)36.647<0.0010.933P vs P + MO200, p < 0.001; P vs P + MO400, p < 0.001; C vs P + MO400, p < 0.001; P + MO100 vs P + MO400, p = 0.025C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin-1 beta; SOD, superoxide dismutase; MDA, malondialdehyde; GPx, glutathione peroxidase.H values were obtained from the Kruskal-Wallis test. Pairwise comparisons were performed using Dunn's post-hoc test with Holm adjustment for multiple testing. Only statistically significant pairwise comparisons are shown. Effect sizes are reported as epsilon-squared (ε2). Kruskal-Wallis test results, effect sizes, and significant pairwise comparisons for serum inflammatory, oxidative stress, and antioxidant parameters. C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin-1 beta; SOD, superoxide dismutase; MDA, malondialdehyde; GPx, glutathione peroxidase. H values were obtained from the Kruskal-Wallis test. Pairwise comparisons were performed using Dunn's post-hoc test with Holm adjustment for multiple testing. Only statistically significant pairwise comparisons are shown. Effect sizes are reported as epsilon-squared (ε2). In the pairwise comparisons with Dunn's post-hoc test and Holm adjustment, IL-6 levels were significantly higher in the P group than in the C group (adjusted p < 0.001), the P + MO200 group (adjusted p = 0.002), and the P + MO400 group (adjusted p = 0.002). For TNF-α, the C group showed significantly lower values than the P group (adjusted p < 0.001), the P + MO100 group (adjusted p = 0.001), and the P + MO200 group (adjusted p = 0.034). For IL-1β, the P group had significantly higher levels than the C group (adjusted p < 0.001), the P + MO200 group (adjusted p = 0.005), and the P + MO400 group (adjusted p = 0.006). In addition, IL-1β levels were significantly higher in the P + MO100 group than in the P + MO200 group (adjusted p = 0.018). For oxidative stress and antioxidant parameters, SOD values were significantly lower in the P group than in the P + MO200 group (adjusted p = 0.024) and the P + MO400 group (adjusted p < 0.001). In addition, the C group had lower SOD levels than the P + MO400 group (adjusted p = 0.050), and the P + MO100 group also had lower SOD levels than the P + MO400 group (adjusted p = 0.050). MDA levels were significantly higher in the P group than in the C group (adjusted p = 0.005), the P + MO200 group (adjusted p = 0.002), and the P + MO400 group (adjusted p = 0.022). GPx values were significantly lower in the P group than in the P + MO200 group (adjusted p < 0.001) and the P + MO400 group (adjusted p < 0.001). In addition, the C group had lower GPx values than the P + MO400 group (adjusted p < 0.001), and the P + MO100 group had lower GPx values than the P + MO400 group (adjusted p = 0.025). Serum urea, creatinine, ALT, and AST levels did not differ significantly among the groups (urea: p = 0.067; creatinine: p = 0.117; ALT: p = 0.177; AST: p = 0.832) (Table 3). Table 3Serum Urea, Creatinine, ALT, and AST levels in the experimental groups.Table 3Group CGroup PGroup P + MO100Group P + MO200Group P + MO400p-valueUrea30.38 ± 1.9229.50 ± 2.3927.11 ± 3.0227.22 ± 2.1123.44 ± 2.300.067Creatinine0.55 ± 0.030.54 ± 0.040.56 ± 0.030.52 ± 0.040.54 ± 0.020.117ALT63.50 ± 6.8065.50 ± 15.2952.56 ± 9.0363.89 ± 7.3960.56 ± 21.170.177AST103.0 ± 8.32102.63 ± 15.12100.33 ± 9.31101.89 ± 14.76110.22 ± 19.430.832C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera.Data are presented as mean ± standard deviation. Overall group comparisons for serum urea, creatinine, ALT, and AST levels were performed using the Kruskal-Wallis test. Serum Urea, Creatinine, ALT, and AST levels in the experimental groups. C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. Data are presented as mean ± standard deviation. Overall group comparisons for serum urea, creatinine, ALT, and AST levels were performed using the Kruskal-Wallis test. Histopathological evaluation Histopathological parameters showed significant overall differences among the groups. According to the Kruskal-Wallis test, significant group effects were observed for inflammatory cell counts (H = 19.972, p < 0.001, ε2 = 0.456), osteoblast counts (H = 24.545, p < 0.001, ε2 = 0.587), and osteoclast counts (H = 15.444, p = 0.004, ε2 = 0.327) (Table 4; Fig. 1). Table 4Histopathological findings and Kruskal-Wallis test results in the study groups.Table 4Group CGroup PGroup P + MO100Group P + MO200Group P + MO400Hp-valueε2Inflammatory Cell Counts0.75 ± 1.393.75 ± 1.043.25 ± 0.460.62 ± 1.190.88 ± 1.2519.972<0.0010.456Osteoblast102.38 ± 13.6264.88 ± 14.4768.38 ± 14.6281.75 ± 6.5495.67 ± 11.9824.545<0.0010.587Osteoclast2.63 ± 1.518.50 ± 3.898.38 ± 5.835.75 ± 2.495.33 ± 1.9415.4440.0040.327C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera.Data are presented as mean ± standard deviation. Overall group comparisons were performed using the Kruskal-Wallis test. Pairwise comparisons were conducted using Dunn's post-hoc test with Holm adjustment for multiple testing, and only statistically significant pairwise differences are reported in the Results section. Effect sizes are reported as epsilon-squared (ε2). Histopathological findings and Kruskal-Wallis test results in the study groups. C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. Data are presented as mean ± standard deviation. Overall group comparisons were performed using the Kruskal-Wallis test. Pairwise comparisons were conducted using Dunn's post-hoc test with Holm adjustment for multiple testing, and only statistically significant pairwise differences are reported in the Results section. Effect sizes are reported as epsilon-squared (ε2). In the pairwise comparisons with Dunn's post-hoc test and Holm adjustment, inflammatory cell counts were higher in the P group than in the C group (adjusted p = 0.032) and the P + MO200 group (adjusted p = 0.032). In addition, inflammatory cell counts were higher in the P + MO100 group than in the C group (adjusted p = 0.016), the P + MO200 group (adjusted p = 0.016), and the P + MO400 group (adjusted p = 0.044). For osteoblast counts, the C group showed higher values than the P group (adjusted p < 0.001) and the P + MO100 group (adjusted p = 0.002). In addition, osteoblast counts were higher in the P + MO400 group than in the P group (adjusted p = 0.010) and the P + MO100 group (adjusted p = 0.030). For osteoclast counts, the C group showed lower values than the P group (adjusted p = 0.003) and the P + MO100 group (adjusted p = 0.016). No other pairwise comparison reached statistical significance after adjustment. Histomorphometric evaluation Alveolar bone level (ABL) showed a significant overall difference among the groups according to the Kruskal-Wallis test (H = 10.907, p = 0.028, ε2 = 0.300) (Table 5; Fig. 2, Fig. 3). Table 5Histomorphometric alveolar bone level findings and Kruskal-Wallis test results in the study groups.Table 5Group CGroup PGroup P + MO100Group P + MO200Group P + MO400Hp-valueε2Alveolar bone level (μm)81.44 ± 21.69247.67 ± 23.95245.32 ± 49.30171.25 ± 60.94198.03 ± 62.5310.9070.0280.300C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera.Data are presented as mean ± standard deviation. Overall group differences were assessed using the Kruskal-Wallis test. Pairwise comparisons were performed using Dunn's post-hoc test with Holm adjustment for multiple testing, and statistically significant pairwise differences are reported in the Results section. Effect sizes are reported as epsilon-squared (ε2). Histomorphometric alveolar bone level findings and Kruskal-Wallis test results in the study groups. C, control group; P, periodontitis group; P + MO100, periodontitis treated with 100 mg/kg/day Moringa oleifera; P + MO200, periodontitis treated with 200 mg/kg/day Moringa oleifera; P + MO400, periodontitis treated with 400 mg/kg/day Moringa oleifera. Data are presented as mean ± standard deviation. Overall group differences were assessed using the Kruskal-Wallis test. Pairwise comparisons were performed using Dunn's post-hoc test with Holm adjustment for multiple testing, and statistically significant pairwise differences are reported in the Results section. Effect sizes are reported as epsilon-squared (ε2). In the pairwise comparisons with Dunn's post-hoc test and Holm adjustment, ABL was significantly higher in the P + MO400 group than in the C group (adjusted p = 0.014). No other pairwise comparison reached statistical significance after adjustment. Discussion This study showed that MO was associated with favorable inflammatory, oxidative, and bone-related changes in rats with ligature-induced periodontitis. The main contribution of the present study lies in its dose-comparative design, which evaluated three oral MO doses across biochemical, histopathological, and histomorphometric outcomes. In line with previous reports, our findings more clearly supported beneficial effects at the 200 and 400 mg/kg/day doses, although dose-related differences should be interpreted cautiously.19,23 The ligature model used in this study is consistent with previous reports showing that a 15-day ligation period produces optimal alveolar bone loss.24,25 MO doses were selected based on prior studies in rats, which reported safety and efficacy without hepatotoxic or nephrotoxic findings.26,27 Inflammation and oxidative stress are central features of periodontal disease. Consistent with earlier studies, MO treatment in the present study was associated with a more favorable inflammatory and oxidative profile, particularly in the MO200 and MO400 groups. After multiple-comparison adjustment, the clearest support was observed for IL-6, IL-1β, SOD, GPx, and MDA, whereas the findings for TNF-α were less consistent. Periodontitis is typically associated with elevated MDA levels and reduced SOD and GPx activity,28,29 and antioxidants such as Pistacia eurycarpa Yalt and caffeic acid have also been reported to attenuate these changes in experimental periodontitis.30,31 In our study, MO200 was mainly associated with higher SOD and GPx values, whereas MO400 showed a broader pattern characterized by higher SOD and GPx together with lower MDA levels compared with the untreated periodontitis group. In contrast, the MO100 group showed more limited support after adjustment. The more limited effects observed in the MO100 group may indicate that this dose remained below the threshold required to produce a consistent anti-inflammatory and antioxidant response in this experimental model. This may reflect a dose-dependent pharmacological effect of MO; however, this interpretation should be made cautiously, particularly because the extract was not chemically standardized. Taken together, these findings support the anti-inflammatory and antioxidant potential of MO, particularly at the 200 and 400 mg/kg/day doses, although dose-related differences should be interpreted cautiously.32,33 Given the growing interest in host-modulatory strategies that limit periodontal tissue destruction, MO may represent a promising adjunctive agent in the management of periodontitis.30,34 Significant overall group differences were also observed in osteoblast counts, osteoclast counts, and histomorphometric alveolar bone level. In line with previous studies, the histopathological findings showed a more favorable pattern in the MO200 and MO400 groups, suggesting a beneficial effect of MO on bone remodeling-related cellular changes.35,36 However, the histomorphometric findings were more limited after multiple-comparison adjustment and should therefore be interpreted cautiously. Only one previous study has directly evaluated MO in experimental periodontitis,23 and our findings are generally consistent with that report. Rather than representing the first study on this topic, the present work extends the existing preclinical literature by comparing three oral dose levels and assessing biochemical, histopathological, and histomorphometric outcomes together. Although the findings more clearly supported beneficial effects at the 200 and 400 mg/kg/day doses, direct translation to human disease remains limited, and further preclinical and clinical studies are needed. In the present study, serum biomarkers were used to assess the systemic inflammatory and oxidative response, whereas histopathological and histomorphometric analyses were included to provide site-related evidence. Nevertheless, the absence of local molecular periodontal markers should be acknowledged when interpreting these findings. This study has certain limitations. First, inflammatory cytokines and oxidative stress parameters were evaluated in serum rather than directly in periodontal tissues. Although serum biomarkers provide useful information on the systemic response associated with experimental periodontitis, they do not fully reflect the local periodontal inflammatory microenvironment. While histopathological cell counts and histomorphometric alveolar bone measurements were included to provide local tissue-related evidence, gingival tissue cytokine expression and site-specific oxidative stress analyses would have offered more disease-specific information. Another limitation of the present study is that the MO extract was characterized procedurally but not chemically standardized using specific marker compounds or chromatographic profiling methods such as HPLC or GC-MS. Therefore, variability in the phytochemical composition of the extract cannot be completely excluded. In addition, micro-computed tomography (micro-CT) was not employed; therefore, bone loss was evaluated only by histomorphometric methods. Future studies using micro-CT and molecular approaches are warranted to provide more comprehensive, three-dimensional, and mechanistic insights into the effects of MO on periodontal disease. Conclusions In this experimental study, oral administration of MO was associated with favorable changes in periodontal inflammation, oxidative stress, and bone-related outcomes in a ligature-induced rat model of periodontitis. The findings were more clearly supported at the 200 and 400 mg/kg/day doses, whereas dose-related differences should be interpreted cautiously. These results support the potential of MO as an adjunctive agent in the management of periodontitis; however, further studies, particularly clinical trials, are needed to confirm its efficacy and safety in humans. Ethics statement Decision The thesis project entitled “The Effects of Moringa oleifera on Expert of the Local Ethics Committee for Animal Experiments. The thesis project entitled “The Effects of Moringa oleifera on Experimental Periodontitis: Periodontal Inflammation and Oxidative Stress Parameters”, submitted by Assistant Professor Fatma UÇAN YARKAÇ from the Department of Periodontology, Faculty of Dentistry, Necmettin Erbakan University; Assistant Professor Rahim KOCABAŞ from the Department of Biochemistry, Faculty of Medicine, Karamanoğlu Mehmetbey University; and Assistant Professor Fahriye KILIÇ from the Department of Medical Pathology, Meram Faculty of Medicine, Necmettin Erbakan University, was evaluated with the participation of 11 committee members. It was reported that a total of 40 rats would be used in the project, divided into 5 groups, and that the animals would be sacrificed by cervical dislocation under anesthesia. Taking into consideration that the applicant fulfills the responsibilities specified in the relevant articles of the Directive of the Local Ethics Committee for Animal Experiments of the Experimental Medicine Application and Research Center (KONÜDAM) of Necmettin Erbakan University; that the ethical principles related to animal experimentation will be strictly adhered to; that the experimental procedures will be carried out by a researcher holding a certificate for the use of experimental animals; and that the study was prepared in compliance with the directive provisions, it was decided, by a majority vote, that the project is “Appropriate” in terms of animal use ethics. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References